EyePoint, Inc. Operating Lease Cost
EyePoint, Inc. (EYPT) reported Operating Lease Cost of $400.00 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2024-05-09
- EyePoint, Inc. operating lease, cost for the quarter ending 2024-03-31 was $400.00K, a 0.00% change year-over-year.
- EyePoint, Inc. operating lease, cost for the quarter ending 2023-03-31 was $400.00K.
- EyePoint, Inc. operating lease, cost for fiscal 2023 was $1.40M, a 16.67% increase from fiscal 2022.
- EyePoint, Inc. operating lease, cost for fiscal 2022 was $1.20M.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 12 month |
|---|---|---|
| 2024-03-31 | $400.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $1.40M 10-K · filed 2024-03-08 | |
| 2023-03-31 | $400.00K 10-Q · filed 2024-05-09 | |
| 2022-12-31 | $1.20M 10-K · filed 2024-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |